4,4-Dichlorobenzhydrol

Catalog No.: 
ACWPRA916
CAS No.: 
90-97-1
Molecular Formula: 
C13H10Cl2O
Molecular Weight: 
253.13
4,4-Dichlorobenzhydrol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$130.00In stockInquiry
500g98%$490.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4-Dichlorobenzhydrol
IUPAC Namebis(4-chlorophenyl)methanol
MDL No.MFCD00000629
Molecular FormulaC13H10Cl2O
Molecular Weight253.13
SMILESOC(C1=CC=C(Cl)C=C1)C2=CC=C(Cl)C=C2
InChI KeyPHUYGURFBULKPA-UHFFFAOYSA-N
SynonymBenzenemethanol, 4-chloro-alpha-(4-chlorophenyl)- | DTXSID5075367 | Bis(4-chlorophenyl) carbinol | Bis(4-chlorophenyl)methanol # | 4,4'-Dichlorobenzhydrol | Bis(4-chlorophenyl--d4)Methyl Alcohol | CHEBI:190399 | FT-0617036 | Z104477892 | Bis(4-chloropheny
CAS No.90-97-1
PubChem CID7033

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWPRA916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHMYB607 route compound structure diagram
    ACHMYB60790-98-2In Stock
  2. Then
  3. ACWPRA916 route product structure diagram
    ACWPRA91690-97-1In Stock
Inquiry

2. ACWPRA916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMIZA189 route compound structure diagram
    ACMIZA189106-39-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWPRA916 route product structure diagram
    ACWPRA91690-97-1In Stock
Inquiry

3. ACWPRA916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWPRA916 route product structure diagram
    ACWPRA91690-97-1In Stock
Inquiry

Comments (0)